Kamada (KMDA) Cash & Current Investments (2012 - 2026)
Kamada's (KMDA) quarterly Cash & Current Investments came in at $73.1 million in Q1 2026, down 4.07% YoY from $76.2 million in Q1 2025, and down 3.33% on a QoQ basis from $75.7 million in Q4 2025.
Kamada (KMDA) Cash & Current Investments (2012 - 2026) Analysis & Trends
Kamada (KMDA) has 15 years of Cash & Current Investments data on file, last reported at $73.1 million in Q1 2026.
- Quarterly Cash & Current Investments fell 4.07% year-over-year to $73.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $73.1 million (down 4.07% YoY) and the FY2025 annual result came in at $75.7 million, down 3.59% from the prior year.
- Cash & Current Investments declined to $73.1 million in Q1 2026, from $75.7 million in the prior quarter.
- In the past five years, Cash & Current Investments ranged from a high of $31.3 billion in Q3 2022 to a low of $29933.0 in Q2 2022.
- A 5-year average of $1.9 billion and a median of $56.5 million in 2024 frame the typical range for Cash & Current Investments.
- Annual changes were most pronounced in 2022 — Cash & Current Investments slumped 99.97% — and 2023, when it soared 72689.23%.
- Tracing KMDA's Cash & Current Investments over 5 years: stood at $34.3 million in 2022, then soared by 62.83% to $55.8 million in 2023, then jumped by 40.68% to $78.5 million in 2024, then fell by 3.59% to $75.7 million in 2025, then slipped by 3.33% to $73.1 million in 2026.
- The last three Cash & Current Investments figures came in at $73.1 million (Q1 2026), $75.7 million (Q4 2025), and $72.0 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.05 Bn | 43.08 Bn | - | 963.33 Mn |
| 2 | Teva Pharmaceutical Industries | 43.39 Bn | 39.74 Bn | 2.15 Bn | 3.66 Bn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | 1.68 Bn |
| 4 | Takeda Pharmaceutical | 28.78 Bn | 22.99 Bn | 5.10 Bn | 5.80 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | 2.66 Bn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | 886.50 Mn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | 389.80 Mn |
| 8 | Elanco Animal Health | 11.92 Bn | 11.39 Bn | 798.00 Mn | 530.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 9.99 Bn | - | 164.00 Mn |
| 10 | Kamada | 459.44 Mn | 429.97 Mn | 22.47 Mn | 29.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 70.13 Mn |
| Mar 31, 2026 | 73.15 Mn |
| Dec 31, 2025 | 75.67 Mn |
| Sep 30, 2025 | 72.00 Mn |
| Jun 30, 2025 | 65.99 Mn |
| Mar 31, 2025 | 76.25 Mn |
| Dec 31, 2024 | 78.48 Mn |
| Sep 30, 2024 | 72.00 Mn |
| Jun 30, 2024 | 56.55 Mn |
| Mar 31, 2024 | 48.19 Mn |
| Dec 31, 2023 | 55.79 Mn |
| Sep 30, 2023 | 52.60 Mn |
| Jun 30, 2023 | 21.79 Mn |
| Mar 31, 2023 | 27.12 Mn |
| Dec 31, 2022 | 34.26 Mn |
| Sep 30, 2022 | 31.25 Bn |
| Jun 30, 2022 | 29,933.00 |
| Mar 31, 2022 | 21.97 Mn |
| Dec 31, 2021 | 145.29 Mn |
| Sep 30, 2021 | 99.84 Mn |